Literature DB >> 15987231

Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK.

Eduardo Carracedo-Martínez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15987231     DOI： 10.2165/00019053-200523070-00008

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  8 in total

1.  Changes in osteoarthritis management by general practitioners in the COX2-inhibitor era-concomitant gastroprotective therapy.

Authors:  Stéphane Bouée; Agnès Charlemagne; Francis Fagnani; Philippe Le Jeunne; Catherine Sermet; Florence Naudin; Pierre-Jean Lancry
Journal:  Joint Bone Spine       Date:  2004-05       Impact factor: 4.929

2.  The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.

Authors:  Andreas Maetzel; Murray Krahn; Gary Naglie
Journal:  Arthritis Rheum       Date:  2003-06-15

3.  Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK.

Authors:  Andrew Moore; Ceri Phillips; Elke Hunsche; James Pellissier; Simone Crespi
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 4.  Understanding NSAID-PPI-COX-2 interrelationships.

Authors:  Gurkirpal Singh
Journal:  Drugs Today (Barc)       Date:  2004-03       Impact factor: 2.245

Review 5.  Review article: appropriate use of proton pump inhibitors with traditional nonsteroidal anti-inflammatory drugs and COX-2 selective inhibitors.

Authors:  M B Kimmey; A Lanas
Journal:  Aliment Pharmacol Ther       Date:  2004-02       Impact factor: 8.171

6.  Utilization of nonsteroidal anti-inflammatory drugs and antisecretory agents: a managed care claims analysis.

Authors:  Joshua J Ofman; Enkhe Badamgarav; James M Henning; Kevin Knight; Loren Laine
Journal:  Am J Med       Date:  2004-06-15       Impact factor: 4.965

7.  Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?

Authors:  Mary Teeling; Kathleen Bennett; John Feely
Journal:  Br J Clin Pharmacol       Date:  2004-03       Impact factor: 4.335

8.  A cross-sectional retrospective assessment of anti-arthritic drugs in patients with arthritis in Korea.

Authors:  Myung Chul Lee; Seokhyun Lee; Dong-Churl Suh; Jeeyeon Kim; Sheldon X Kong
Journal:  Curr Med Res Opin       Date:  2003       Impact factor: 2.580
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.